UNISUN Trademark

Trademark Overview


On Wednesday, September 3, 2014, a trademark application was filed for UNISUN with the United States Patent and Trademark Office. The USPTO has given the UNISUN trademark a serial number of 86383810. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, March 27, 2023. This trademark is owned by Orbis Biosciences, Inc.. The UNISUN trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Manufacturing services for others in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, and delayed release systems, clinical manufacturing of drug formulations for others to support clinical trials, fabrication and preparation of active pharmaceutical ingredients for others, technology scale-up services for others, and integration of technology into manufacturing processes for others, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables, all for inner ear delivery

Pharmaceutical drug delivery technology development services; pharmaceutical drug delivery technology development services, namely, research and development in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, and delayed release systems, consisting of selection of drug formulation and delivery systems to optimize performance of active pharmaceutical ingredients, analytic techniques to test drug formulations, analytic services to detect, identify and quantify drug components, stability testing, physical characterization of drug formulations, in-vitro release testing, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables, all for inner ear delivery
unisun

General Information


Serial Number86383810
Word MarkUNISUN
Filing DateWednesday, September 3, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, March 27, 2023
Registration Number4989255
Registration DateTuesday, June 28, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 29, 2015

Trademark Statements


Goods and ServicesManufacturing services for others in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, and delayed release systems, clinical manufacturing of drug formulations for others to support clinical trials, fabrication and preparation of active pharmaceutical ingredients for others, technology scale-up services for others, and integration of technology into manufacturing processes for others, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables, all for inner ear delivery
Pseudo MarkUNISON
Goods and ServicesPharmaceutical drug delivery technology development services; pharmaceutical drug delivery technology development services, namely, research and development in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, and delayed release systems, consisting of selection of drug formulation and delivery systems to optimize performance of active pharmaceutical ingredients, analytic techniques to test drug formulations, analytic services to detect, identify and quantify drug components, stability testing, physical characterization of drug formulations, in-vitro release testing, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables, all for inner ear delivery

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, October 27, 2015
Primary Code040
First Use Anywhere DateThursday, August 28, 2014
First Use In Commerce DateThursday, August 28, 2014

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 12, 2014
Primary Code042
First Use Anywhere DateThursday, August 28, 2014
First Use In Commerce DateThursday, August 28, 2014

Trademark Owner History


Party NameAdare Pharmaceuticals Usa, Inc.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressLawrenceville, NJ 08648

Party NameOrbis Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLenexa, KS 66214

Party NameOrbis Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLenexa, KS 66214

Party NameOrbis Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKansas City, KS 66103

Trademark Events


Event DateEvent Description
Monday, March 27, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, March 27, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, February 15, 2023TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, October 4, 2022POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Tuesday, October 4, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, April 6, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, June 28, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, October 14, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, October 7, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, June 28, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, May 24, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, May 23, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, May 21, 2016STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 26, 2016USE AMENDMENT FILED
Friday, May 20, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 26, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, April 26, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 26, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 23, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 29, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 29, 2015PUBLISHED FOR OPPOSITION
Wednesday, December 9, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 2, 2015EXPARTE APPEAL TERMINATED
Saturday, October 31, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 28, 2015EX PARTE APPEAL-INSTITUTED
Wednesday, October 28, 2015JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, October 28, 2015EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, October 27, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 26, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 26, 2015TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, April 28, 2015NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, April 28, 2015FINAL REFUSAL E-MAILED
Tuesday, April 28, 2015FINAL REFUSAL WRITTEN
Friday, April 10, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 9, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 9, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 19, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 19, 2014NON-FINAL ACTION E-MAILED
Friday, December 19, 2014NON-FINAL ACTION WRITTEN
Tuesday, December 16, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 16, 2014NON-FINAL ACTION E-MAILED
Tuesday, December 16, 2014NON-FINAL ACTION WRITTEN
Sunday, December 14, 2014ASSIGNED TO EXAMINER
Friday, September 12, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 6, 2014NEW APPLICATION ENTERED